NCT02032407View on ClinicalTrials.gov

A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris

PHASE4CompletedINTERVENTIONAL

Enrollment

68

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

September 30, 2014

Conditions

Acne Vulgaris

Interventions

DRUG

Dapsone Gel

Dapsone Gel (Aczone®) applied twice daily to the face for 12 weeks.

Trial Locations (1)

Unknown

Washington D.C.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY